Pettee Investors’s Eli Lilly LLY Stock Holding History

Pettee Investors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Hold	1,066	–	–	0.63%	47
2026 Q1	$996K	Hold	1,066	–	–	0.51%	55
2025 Q4	$1.15M	Hold	1,066	–	–	0.64%	45
2025 Q3	$813K	Hold	1,066	–	–	0.45%	64
2025 Q2	$831K	Hold	1,066	–	–	0.5%	61
2025 Q1	$880K	Hold	1,066	–	–	0.52%	60
2024 Q4	$823K	Hold	1,066	–	–	0.42%	68
2024 Q3	$944K	Hold	1,066	–	–	0.46%	67
2024 Q2	$965K	Hold	1,066	–	–	0.47%	66
2024 Q1	$829K	Sell	1,066 -264	-20%	-$188K	0.35%	77
2023 Q4	$775K	Hold	1,330	–	–	0.34%	78
2023 Q3	$714K	Hold	1,330	–	–	0.34%	80
2023 Q2	$624K	Hold	1,330	–	–	0.28%	83
2023 Q1	$457K	Hold	1,330	–	–	0.22%	91
2022 Q4	$487K	Buy	1,330 +130	+11%	+$46.1K	0.24%	89
2022 Q3	$388K	Hold	1,200	–	–	0.21%	93
2022 Q2	$389K	Hold	1,200	–	–	0.19%	96
2022 Q1	$344K	Hold	1,200	–	–	0.15%	103
2021 Q4	$331K	Hold	1,200	–	–	0.14%	107
2021 Q3	$277K	Hold	1,200	–	–	0.13%	112
2021 Q2	$275K	Hold	1,200	–	–	0.13%	112
2021 Q1	$224K	Buy	+1,200	New	+$235K	0.11%	119

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pettee Investors's LLY Position: Q2 2026 in Review

Pettee Investors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,066 shares worth $1.28M. The position accounts for 0.63% of the portfolio, ranked #47.

Pettee Investors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pettee Investors held 1,066 shares of Eli Lilly worth $1.28M as of Q2 2026.
Pettee Investors left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.63% of Pettee Investors's portfolio in Q2 2026, its #47 holding.
Pettee Investors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pettee Investors's 13F filing for Q2 2026, filed 6 Aug 2026.